DAY ZERO DIAGNOSTICS INC
Boston, MA · Founded 2016 · CIK 0001707003 · Medtech · Acquired
In vitro diagnostic tests and systems for clinical microbiology and infectious disease detection
dayzerodiagnostics.com →- Grants
- $2.3M
- 8 awards
- Sector median: 1
- Raised
- $2.5M
- 1 Form D · May 2017
- 112 months since last filing
- Contracts
- $14K
- 1 award · Health and Human S
- #620 of 4531 in medtech
- Patents
- 15
- 3 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,502,567 | |
| Federal grant | Department of Health and Human Services · Phase I · Automated algorithm for rapid, scalable determination of hospital acquired bacterial infections using whole genome sequencing | $224,444 | |
| Federal grant | Department of Health and Human Services · Phase I · Automated algorithm for rapid, scalable determination of hospital acquired bacterial infections using whole genome sequencing | $224,444 | |
| Federal grant | Department of Health and Human Services · Phase I · Next-day whole genome sequencing and analysis using nanopore sequencing for real-time outbreak and transmission determination in healthcare facilities | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Next-day whole genome sequencing and analysis using nanopore sequencing for real-time outbreak and transmission determination in healthcare facilities | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Novel Whole Genome Sequencing-based Platform for Rapid Identification and Antimicrobial Profiling of Uropathogens | $303,932 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Novel Whole Genome Sequencing-based Platform for Rapid Identification and Antimicrobial Profiling of Uropathogens | $303,932 | |
| Federal grant | Department of Health and Human Services · Phase I · EpiXact-FMT: A metagenomic, pharmacovigilance assay for microbiota therapeutics safety | $299,989 | |
| Federal grant | Department of Health and Human Services · Phase I · EpiXact-FMT: A metagenomic, pharmacovigilance assay for microbiota therapeutics safety | $299,989 | |
| Federal contract | Department of Health and Human Services · Day Zero Diagnostics Testing Services Needed By The Department Of Laboratory Medicine (dlm) For Existing Project. | $13,925 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 617 | LUMITEX, INC. | $15K | $355K |
| 618 | KEY TECHNOLOGIES, INC. | $14K | — |
| 619 | HYQ RESEARCH SOLUTIONS, LLC | $14K | — |
| 620 | DAY ZERO DIAGNOSTICS INC | $14K | $2.5M |
| 621 | Sientra, Inc. | $14K | $65M |
| 622 | EnteroTrack, LLC | $13K | $4.9M |
| 623 | MERCATOR MEDSYSTEMS, INC. | $13K | $17M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Laura DavisDirector
- Miriam HuntleyExecutive Officer
- Douglas KwonDirector
- Jong LeeDirector · Executive Officer
- Dougal MclaurinExecutive Officer
- Jeff MirvissDirector
Patents
- An Improved Method Of Preparing Clinical Samples For Nucleic Acid Amplificationgranted
- Universal Primers For Rapid Bacterial Genome Detectionapplication
- Selective Enrichment Of A Population Of Dna In A Mixed Dna Sample Through Targeted Suppression Of Dna Amplificationgranted
- Method Of Preparing Clinical Samples For Nucleic Acid Amplificationgranted
- Universal Primers For Rapid Bacterial Genome Detectionapplication
- Methods For Enriching Microorganisms From Low Abundance Clinical Samples For Dna Sequencingapplication
- Universal Primers For Rapid Bacterial Genome Detectionapplication
- An Improved Method Of Preparing Clinical Samples For Nucleic Acid Amplificationapplication
- Method Of Preparing Clinical Samples For Nucleic Acid Amplificationapplication
- Selective Enrichment Of A Population Of Dna In A Mixed Dna Sample Through Targeted Suppression Of Dna Amplificationapplication
- Split Sample Processingapplication
- Selective Enrichment Of Non-host Dna Through Suppression Of Host Dna Amplificationapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.